MedPath
HSA Approval

STELARA SOLUTION FOR INJECTION IN PRE-FILLED PEN 90MG/1ML

SIN17103P

STELARA SOLUTION FOR INJECTION IN PRE-FILLED PEN 90MG/1ML

STELARA SOLUTION FOR INJECTION IN PRE-FILLED PEN 90MG/1ML

September 26, 2024

JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantJOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

SUBCUTANEOUS

Medical Information

L04AC05

Manufacturer Information

JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE. LTD.

Cilag AG

Baxter Pharmaceutical Solutions LLC

Active Ingredients

Ustekinumab

90mg/1ml

Ustekinumab

Documents

Package Inserts

Stelara PI.pdf

Approved: September 26, 2024

Download

Patient Information Leaflets

Stelara PIL.pdf

Approved: September 26, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

STELARA SOLUTION FOR INJECTION IN PRE-FILLED PEN 90MG/1ML - HSA Approval | MedPath